PropThink: Biogen Idec’s BG-12 PDUFA Delay is a Buying Opportunity

PropThink: Biogen Idec’s BG-12 PDUFA Delay is a Buying Opportunity

[ACN Newswire] – By Ivan DeryuginThe biotechnology sector can be broken up, at its simplest, into two distinct groups: the Big 4, and every other company. The Big 4 are Amgen (NASDAQ:AMGN), Celgene (NASDAQ:CELG), Gilead … more

View todays social media effects on AMGN

View the latest stocks trending across Twitter. Click to view dashboard

Share this post

Comments (0)